According to Zacks, “National Research Corporation offers analytics and insights that facilitate revenue growth, patient, employee, customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its services include capture, interpretation, transmittal and benchmarking of critical data elements from various healthcare consumers. National Research Corporation is headquartered in Lincoln, Nebraska. “
Separately, TheStreet upgraded National Research Corp. from a hold rating to a buy rating in a research report on Wednesday, August 10th.
Shares of National Research Corp. (NASDAQ:NRCIA) traded up 0.06% during midday trading on Wednesday, reaching $15.57. 2,730 shares of the company’s stock traded hands. National Research Corp. has a 52-week low of $12.47 and a 52-week high of $17.42. The stock’s 50 day moving average price is $16.05 and its 200 day moving average price is $14.92. The firm has a market capitalization of $377.12 million, a P/E ratio of 19.13 and a beta of 1.69.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date is Wednesday, September 28th. National Research Corp.’s dividend payout ratio (DPR) is 68.09%.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with MarketBeat.com's FREE daily email newsletter.